MedTrace Logo

Anatomic Stenosis Severity as a Prognostic Marker in Patients With Low-Flow Low-Gradient Aortic Stenosis Undergoing TAVI

NCT04914481 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2021-06-04

No results posted yet for this study

Summary

The ATLAS TAVI Registry is a retrospective, investigator-initiated, multicenter registry including patients, who underwent Transcatheter Aortic Valve Implantation (TAVI) for classical or paradoxical low-flow, low-gradient aortic stenosis (LFLG AS) with available non-contrast MSCT data on aortic valve calcification (AVC). The main objective of this study is the assessment of outcome after TAVI according to AVC density severity in patients with LFLG AS.

Conditions

  • Low-Flow, Low-Gradient Aortic Stenosis

Sponsors & Collaborators

  • Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

    collaborator OTHER

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Marie-Annick Clavel, PhD · Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada

  • Niklas Schofer, MD · University Heart and Vascular Center Hamburg, Hamburg, Germany

  • Sebastian Ludwig, MD · University Heart and Vascular Center Hamburg, Hamburg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-12-31
Completion
2025-12-31

Countries

  • Canada
  • Denmark
  • France
  • Germany
  • Israel
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04914481 on ClinicalTrials.gov